Lucid Diagnostics
LUCD
30 hedge funds and large institutions have $1.69M invested in Lucid Diagnostics in 2024 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 4 closing their positions.
125% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 4
57% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 7
20% more funds holding
Funds holding: 25 → 30 (+5)
0.38% more ownership
Funds ownership: 3.91% → 4.29% (+0.38%)
31% less capital invested
Capital invested by funds: $2.46M → $1.69M (-$776K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$297K |
| 2 |
Jane Street
New York
|
+$142K |
| 3 |
HF
HRT Financial
New York
|
+$81.8K |
| 4 |
BlackRock
New York
|
+$36.6K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$31K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$190K |
| 2 |
LM
Luminus Management
Houston,
Texas
|
-$72.1K |
| 3 |
BAM
Byrne Asset Management
Kingston,
New Jersey
|
-$9.52K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$8.05K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$2.54K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Bank of America
Charlotte,
North Carolina
| $3 | -$14 | -11 | -79% |
|
27
Qube Research & Technologies (QRT)
London,
United Kingdom
| $1 | -$134 | -103 | -99% |
|
|
TIM
28
Thompson Investment Management
Madison,
Wisconsin
| $1 | +$1 | +1 | New |
|
|
BCM
29
Bridgeway Capital Management
Houston,
Texas
| – | -$190K | -135,000 | Closed |
|
|
BAM
30
Byrne Asset Management
Kingston,
New Jersey
| – | -$9.52K | -6,610 | Closed |
|
|
31
UBS Group
Zurich,
Switzerland
| – | -$8.05K | -5,708 | Closed |
|
|
ASN
32
Advisory Services Network
Atlanta,
Georgia
| – | -$1.08K | -765 | Closed |
|
33
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$141 | -109 | -55% |
|
LUCD Hedge Fund Activity: Q1 2024 in Review
30 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Lucid Diagnostics (LUCD) for Q1 2024, worth a combined $1.69M — down 31% from $2.46M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new LUCD positions and 4 closed out — a net gain of 5 holders — while 11 added to existing stakes and 7 trimmed.
The largest buyer was Vanguard Group, adding an estimated $297K. The largest seller was Bridgeway Capital Management, exiting entirely with an estimated $190K sold.
- 30 institutional investors held Lucid Diagnostics (LUCD) as of Q1 2024, up from 25 in Q4 2023.
- Funds reported $1.69M of Lucid Diagnostics stock for Q1 2024, down 31% quarter-over-quarter.
- 9 funds opened new Lucid Diagnostics positions in Q1 2024 and 4 closed out, a net change of +5 holders.
- The largest Lucid Diagnostics buyer in Q1 2024 was Vanguard Group, an estimated $297K added.
- The largest Lucid Diagnostics seller in Q1 2024 was Bridgeway Capital Management, an estimated $190K sold.
Based on aggregated 13F filings for Q1 2024.